semaglutide for pcos CUAnschutz researchers have published a proof-of-concept study demonstrating that injectable may offer meaningful reproductive benefits women with polyendocrine metabolic ovarian syndrome (PMOS), formerly known as PCOS. “Women with PMOS Semaglutide and metformin improve menstrual

Commercially insured patients show a similar trend: 36% who began GLP-1 therapy in 2024 did not add another drug within a year, a significant rise from 13% in 2020

doi: 10.1016/J.NPEP.2018.07.003

doi: 10.1007/s10620-025-08964-6 104 AndersonSRAyoubMCoatsSMcHenrySTanTDeepakP

Past medical history was significant for morbid obesity (current weight 286 kg), pulmonary embolism and deep vein thrombosis 4 years prior, previously treated with warfarin

Photo Credit: Jessica Kielman, Baldwin Publishing 40 mins This dish pairs juicy chicken breasts with fresh tomatoes and herbs for a bright, simple meal

Pharmacists should reinforce that semaglutide remains highly effective but may produce less absolute weight loss than tirzepatide, owing to differing receptor profiles 10